Clinical Trials on Safety、Immunogenicity in Australia
Total 27 results
-
Q32 Bio Inc.CompletedSafety IssuesAustralia
-
CerevanceCompleted
-
Nanjing Immunophage Biotech Co., LtdRecruiting
-
Island PharmaceuticalsBeyond Drug DevelopmentCompletedSafety and TolerabilityAustralia
-
Annexon, Inc.Nucleus Network LtdCompletedSafety and Tolerability in Healthy VolunteersAustralia
-
Annexon, Inc.TerminatedSafety and Tolerability in Healthy VolunteersAustralia
-
MingSight Pharmaceuticals Pty LimitedCompletedSafety and PK in Healthy VolunteersAustralia
-
Kepler University HospitalRISC Software GmbH; innovethic eU; FiveSquare GmbHNot yet recruiting
-
Biotronik SE & Co. KGCompletedSafety of MR (Magnetic Resonance)-Conditional ICDsAustralia, Germany, Switzerland, Austria, Singapore
-
SignPath Pharma, Inc.Completed
-
Arch Biopartners Inc.CompletedNone - Study is to Determine Safety in Healthy ParticipantsAustralia
-
Affiris AGCompleted
-
Prof. Peter Gerner, M.D.CompletedEfficacy and Safety Study of Dexmedetomidine as an Additive to Local Anesthetics in Shoulder SurgerySelf Efficacy | Drug SafetyAustria
-
Menzies School of Health ResearchCharles Darwin University; Northern Territory of Australia as represented by... and other collaboratorsRecruitingAboriginal Health | Cultural Safety | Access to Interpreters | Healthcare Provider TrainingAustralia
-
Biotronik SE & Co. KGCompletedSafety of MR (Magnetic Resonance) Conditional CRT-pacemakers and ICDsFrance, Germany, Hungary, Canada, Australia, Austria, Czech Republic, Switzerland
-
Biotronik AGCompletedLong Term Safety of the AMS 1.0Switzerland, Germany, Australia, Belgium, Netherlands
-
Actinogen MedicalICON plcCompletedCognitive Function | Peripheral Neuropathy | Electrocardiography | Central Nervous System | Safety | Healthy Ageing | Cortisol | Cerebrospinal Fluid | Small Fibre NeuropathyAustralia
-
GuerbetCompletedGeneral Safety Profile of DOTAREMArgentina, China, France, Spain, India, United Kingdom, Austria, Germany, Italy, Saudi Arabia
-
University Hospital, Basel, SwitzerlandCompletedPostoperative Complications | Intraoperative Complications | Patient Safety | Risk ManagementNew Zealand, Switzerland, United States, Netherlands, Spain, Austria, Turkey, United Kingdom, Australia, Greece, Ireland, Italy
-
BlueSky Immunotherapies GmbHEnrolling by invitation
-
Medical University of ViennaUnknownGlaucoma | Safety Issues | Efficacy, Self | Post-Op Complication | Glaucoma SurgeryAustria
-
Medical University InnsbruckCompletedEmergencies | Pain, Acute | Trauma, Multiple | Safety | Analgesics | Accident | Field Physician Care | HypnoticsAustria
-
BeiGeneRecruitingLocally Advanced or Metastatic Solid Tumors for Phase 1,Dose Escalation and Phase 2 Safety Lead-in, HNSCC, NSCLC and RCC Participants for Phase 2Australia, United States, Spain, France, Italy, Korea, Republic of, Poland
-
Novartis PharmaceuticalsUniversity of PennsylvaniaRecruitingLong Term Safety of Patients Receiving CAR-T in an Eligible Clinical Trial or Managed Access ProgramUnited States, Japan, Australia, Germany, Spain, Belgium, Taiwan, Italy, Canada, Israel, Singapore, United Kingdom, Denmark, Finland, Norway, Austria, Netherlands, France
-
AmgenCompletedEvaluate the Safety and Efficacy of Denosumab in Pediatric Subjects With | Glucocorticoid-induced OsteoporosisUnited States, Bulgaria, Turkey, Italy, Australia, Belgium, Canada, Colombia, India, Mexico, Peru, Russian Federation, Ukraine
-
Novartis PharmaceuticalsCompletedLong-term Safety of TIPItaly, Spain, Germany, United States, Australia, Canada, Hungary, Mexico, Argentina
-
Novartis PharmaceuticalsCompletedMetastatic Colorectal Cancer | Gastric Cancer | Advanced Solid Tumors | Metastatic Breast Cancer | Gastroesophageal Junction Cancer | Recurrent Glioblastoma Multiforme | Advanced Pancreatic Adenocarcinoma | Safety | Triple Negative Metastatic Breast Cancer | Dose Escalation | Preliminary Efficacy | Hormone Receptor...Canada, United Kingdom, Spain, Germany, Italy, Belgium, Australia, United States